Abstracts of the 2011 International Congress of the
The spate of new drugs is largely due to the increased complexity and volatility of the European drugs market In addition the speedy appearance of new attractive alternatives to controlled drugs underlines the ability of this market to respond rapidly to changes in the legal status of psychoactive substances